Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Predictive Clinical and Biological Parameters in Gynecological Cancer - GC-BIO-IPC 2013-010 (GC-BIO)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by Institut Paoli-Calmettes
Information provided by (Responsible Party):
Institut Paoli-Calmettes Identifier:
First received: October 30, 2013
Last updated: December 31, 2013
Last verified: December 2013
Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation

Condition Intervention
Ovarian Cancer
Endometrium Cancer
Cervix Cancer
Other: gynecological cancer

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: Predictive Clinical and Biological Parameters in Gynecological Cancer - GC-BIO-IPC 2013-010

Resource links provided by NLM:

Further study details as provided by Institut Paoli-Calmettes:

Primary Outcome Measures:
  • molecular alteration in gynecological cancer [ Time Frame: average of 4 weeks after diagnosis ]
    gene expression level

Secondary Outcome Measures:
  • relation between molecular alteration and clinical and histological characteristics [ Time Frame: up to 10 years ]
    hazard ratio between molecular alteration and clinico-histological characteristics

Estimated Enrollment: 300
Study Start Date: December 2013
Estimated Study Completion Date: December 2028
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: gynecological cancer
blood and tumor samples
Other: gynecological cancer
blood and tumor samples


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • gynecological cancer
  • age > 18
  • signed informed consent

Exclusion Criteria:

- emergency

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01977274

Contact: Agnès BOYER CHAMMARD 33491223778

Institut Paoli Calmettes Recruiting
Marseille, France, 13 009
Contact: Agnes BOYER CHAMMARD, MD         
Principal Investigator: Eric LAMBAUDIE, MD         
Sponsors and Collaborators
Institut Paoli-Calmettes
  More Information

Additional Information:
Responsible Party: Institut Paoli-Calmettes Identifier: NCT01977274     History of Changes
Other Study ID Numbers: GC-BIO-IPC 2013-010
Study First Received: October 30, 2013
Last Updated: December 31, 2013

Keywords provided by Institut Paoli-Calmettes:
ovarian, endometrium, cervix cancer

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Endometrial Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female processed this record on April 28, 2017